15Jul 2023
Cardiovascular Safety of Testosterone-Replacement Therapy

Cardiovascular Safety of Testosterone-Replacement Therapy

The study evaluated the cardiovascular safety of testosterone-replacement therapy in middle-aged and older men with hypogonadism. The trial included 5246 men with cardiovascular disease risk factors. The study found that testosterone therapy was non-inferior to placebo in terms of major adverse cardiac events, including death from cardiovascular causes, nonfatal heart attacks, and strokes. However, there was a higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group.

  • #cardiology

Like

Save

Share